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Although tumors on the surface of the skin are considered to be easily recognizable, neglected advanced skin neoplasms are
encountered even in the 21st century. There can be numerous causes of the delay in the diagnosis: fear of the diagnosis and
the treatment, becoming accustomed to a slowly growing tumor, old age, a low social milieu, and an inadequate hygienic culture
are among the factors leading some people not to seek medical advice. The treatment of such advanced neoplasms is usually
challenging. The therapy of neglected cases demands an individual multidisciplinary approach and teamwork. Basal cell carcinoma
(BCC), the most common cutaneous tumor, usually develops in the elderly, grows slowly, and has an extremely low metastatic
potential; these factors are suggesting that BCCsmight well be the “ideal candidates” for neglected tumors. Five neglected advanced
cases of BCC were diagnosed in our dermatological institute between 2000 and 2009. The clinical characteristics and treatment
modalities of these neoplasms are discussed, together with the possible causes of the neglect.
1. Introduction
Tumors on the surface of the skin are generally visible
and considered to be easily recognizable both for health-
care professionals and for the patients themselves. However,
people with neglected advanced skin neoplasms are still
encountered in dermatological practice in the 21st century.
There can be numerous causes of the delay in the diagnosis:
the person may fear the diagnosis and the treatment or
become accustomed to the usually slowly-growing tumor.
Old age, a low social milieu, and an inadequate hygienic
culture may also be factors explaining why some people are
not aware of the significance of a delayed diagnosis.
Basal cell carcinoma (BCC) is the most common cuta-
neous tumor and one of the most frequent skin diseases
observed by dermatologists [1, 2]. Most of these tumors arise
in the head and neck area, particularly in the elderly, and
usually grow slowly. The metastatic potential is very low and
is mainly detected in association with aggressive or long-
standing, large neglected tumors [1–4]. The characteristics of
BCCs suggest that they might well be the “ideal candidates”
for neglected tumors. During the past 10 years, 5 neglected
advanced cases of BCC were diagnosed in our regional center
of dermatological oncology.
2. Case Reports
The main clinical characteristics of the patients and the
treatment applied are listed in Table 1.
Case 1. When a 44-year-old male first sought for medical
advice in December 2009, he had already had a mutilating,
horrifying tumor on the right side of his face for 10 months.
He lived alone in a farmhouse in a rural, but quite densely
populated area. Two years previously, his own dog had
clawed on the right side of the patient’s nose, with the injury
leaving a scar. Eleven months before his presentation, he had
suffered another minor injury in the same region caused by
a splinter of wood. A gradually growing, ulcerating lesion
had subsequently developed on his face (Figure 1). The
clinical diagnosis was BCC, but the possibility of Wegener’s
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Table 1: Data on the neglected BCC patients and their treatment (BCC: basal cell carcinoma, SCC: squamous cell carcinoma).
Case no Age/sex Residence Duration, clinical history Diagnosis Treatment
1 44 y male farm
injury 2 years previously,
growing lesion for 10 months
BCC
surgical
removal
2 96 y female town >2 years BCC radiotherapy
3 63 y male town
several years, rapidly growing
for months
BCC with suppurative
inflammation
surgical
removal
4 84 y male village 1 year BCC
surgical
removal
5 68 y male village
1 year, immunosuppressed
(renal transplant) patient
neck: BCC
face, ear: SCC
surgical
removal
Figure 1: Case 1: A mutilating tumor on the right side of the
patient’s face.
Figure 2: Case 1: The histopathology of the first biopsy specimen
confirmed the diagnosis of BCC.
granulomatosis also emerged together with a suspicion of
leprosy or some other bacterial infection. The CT scan
revealed an extensive bone defect: the maxillary sinus had
perished, half of the nasal bone and the zygomatic arch
were missing, and the external wall of the frontal sinus was
involved. As three types of bacteria were identified, intra-
venous antibiotic treatment was started. Multiple biopsies
confirmed the presence of BCC (Figure 2). The tumor was
resected at the Oral and Maxillofacial Surgery Department
and the defect was covered with a frontotemporal rotation
flap and a latissimus dorsi musculocutaneous free flap. In
the postoperative period, the patient suffered a right-sided
temporal lobe emollition of the brain, resulting in left-sided
hemiplegia. The skin layer of the flap necrotized, but the
Figure 3: Case 1: The patient is tumor-free, but his face has not
been reconstructed functionally or esthetically.
Figure 4: Case 2: An ulcerated tumor in the right parieto-occipital
region, with bone destruction.
muscular layer remained intact, and healed by secondary
epithelialization. After 6 months, recurrences around the
mouth necessitated repeated excisions with a forearm fascio-
cutaneous free flap reconstruction. This flap necrotized in
full thickness and it had to be removed, and the defect
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Figure 5: Case 3: An exophytic, ulcerated tumor mass in the middle
of the back, with suppurative inflammation and abscess formation.
Figure 6: Case 4: An ulcerated tumor on the patient’s presternal
area.
was closed in a direct manner. The patient is now tumor-
free, but his face has not been reconstructed functionally
or esthetically (Figure 3). His nutrition is solved, and
physiotherapy has led to a significant improvement in his
extremity movements: he can walk alone and use his left
hand.
Case 2. A 96-year-old female, living in a small town,
presented in November 2007 with a 2-year history of a
growing tumorous mass in the right inguinal region. The
tumor was removed and the histopathology confirmed the
presence of squamous cell carcinoma (SCC). At the same
time, an ulcerated tumor on the right parieto-occipital
region of her head was diagnosed clinically as BCC. Excision
or irradiation therapy was planned after the removal of
the inguinal tumor, but the patient did not continue the
treatment. In 2009, she received neurosurgical treatment and
was then referred to dermatology because of her growing
cranial tumor (Figure 4). An incisional biopsy from this
tumor confirmed the diagnosis of BCC. In view of her age
and the size and extent of the tumor, the multidisciplinary
oncology team decided on irradiation therapy. This caused
the tumor to regress, leaving an ulcer with visible bone at
the base. In the meantime, the SCC recurred in the left groin
Figure 7: Case 5: A BCC on the right side of the neck and two
smaller SCCs in the preauricular region and on the ear.
lymph nodes, but no other dissemination was detected and
the tumor mass remained stable for several months.
Case 3. A 63-year-old man living in an agricultural town had
had a small exophytic skin-colored nodule in the middle of
his back for many years. This had started to grow rapidly
and become ulcerated during the past few months. By his
first medical visit in September 2009, suppurative inflam-
mation with abscess formation had developed in the nearby
dermis (Figure 5). Consequently, an incisional biopsy and
incision of the abscess were initially performed, and systemic
antibiotic therapy was administered. The histopathological
diagnosis was BCC. Laboratory tests revealed that the
patient had previously unrecognized non-insulin-dependent
diabetes mellitus. In a second operation, the whole tumor
was removed with conservative wound care because of the
inflammation. The patient at first participated in regular
surgical followup and treatment of the remaining ulcer, but
he later failed to appear for the oncology followup.
Case 4. An 84-year-old male resident in an agricultural
village presented in September 2008 with numerous actinic
keratoses on his head and neck and with a slowly growing
tumorous mass in the presternal area, which he had observed
one year previously (Figure 6). The tumor which proved
to be a BCC was removed with free surgical margin and
the defect was covered by a mesh-graft skin transplant. At
the same time, an in situ superficially spreading malignant
melanoma in a melanocytic nevus was removed from his
back. The patient has currently been under regular followup
for 2 years.
Case 5. A 68-year-old male, living in a village, underwent
renal transplantation in 1995 and had subsequently received
immunosuppressive therapy. A slowly growing tumor devel-
oped on the right side of his neck one year prior to
his clinical presentation in 2009. Both the clinical and
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the histopathological diagnosis indicated BCC. Additionally,
there were two small SCCs in the preauricular region and on
the right ear (Figure 7).
3. Discussion
Around one-third of giant BCCs result from patients’ neglect
[1, 2, 5]. There can be numerous reasons for delay in
seeking medical advice. The factors are best documented in
malignant melanoma cases [6–8], but nonmelanoma skin
cancers and mesenchymal tumors [9–13] are also seen in
neglected forms from time to time. A low social milieu,
inadequate hygienic culture associated with poverty, and
a low level of knowledge about skin tumors may be the
explanation in some cases. Patients in these circumstances
may not be aware of the possible significance of their growing
lesion, though most of our patients live in towns or villages
where family members, family doctors or neighbors are
easily accessible and media campaigns can reach them. Old
age and a slowly growing, not painful neoplasm may also
result in a delay in seeking medical advice. The patients may
not see properly or not realize the changing and extremely
unpleasant clinical picture or they might accept the slowly,
but continuously progressing situation. Finally a delay may
be caused by an incorrect initial diagnosis, although this
occursmainly withmelanocytic tumors [6]. The organ trans-
planted and/or immunocompromised individuals comprise
a special group. In consequence of the immunosuppression,
skin tumors are more frequent and more rapidly growing in
these individuals.
It is interesting, that although the patients themselves
are more or less aware of the growing tumor, it is usually
some external event that finally impels them to seek medical
advice, for example, a sudden change in the lesion (bleeding
or sudden growth) or encouragement by another person
(a family member or friend) [1–3, 6, 7]. A media campaign
or a news article may sometimes stimulate a person to visit a
physician [6–8].
Another challenging question is the treatment of these
advanced neoplasms. Numerous possibilities are available
for ordinary BCCs: surgical excision, Mohs micrographic
surgery, PDT therapy, cryosurgery, immunotherapy, and
radiotherapy are the most frequently used techniques
[1, 3]. The therapy of neglected cases, however, demands
an individual multidisciplinary approach and teamwork. The
treatment of choice is often surgery (plastic, craniofacial, or
neurosurgery) alone or combined with radiotherapy, with
the help of imaging techniques (CT, MRI, and angiogra-
phy). Reconstruction and a long-term followup are usually
needed, with the cooperation of medical experts. Despite
the choice of the best possible treatment modalities, a rather
unfavorable prognosis and a high recurrence rate are to be
anticipated.
4. Conclusions
Neglected advanced skin tumors can be encountered even
in the 21st century. BCC, the most common cutaneous
tumor, usually develops in the elderly, grows slowly, and
has an extremely low metastatic potential making it an
“ideal candidate” for a neglected tumor. Although there are
many possibilities for the treatment of BCCs, the therapy
of such neglected cases always demands an individual and
multidisciplinary approach and teamwork.
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